NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
35 hedge funds and large institutions have $5.35M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
9
Closed
5
Calls
$46K
Puts
$85K
Net Calls
-$39K
Net Calls Change
-$105K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$383K |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$320K |
| 3 |
Goldman Sachs
New York
|
+$202K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$37.9K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$24.4K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$897K |
| 2 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$389K |
| 3 |
AG
Artal Group
Luxembourg
|
-$315K |
| 4 |
Millennium Management
New York
|
-$29.5K |
| 5 |
BlackRock
New York
|
-$23K |
